Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Diabetes|January 30, 2004
Role of peroxisome proliferator-activated receptor-gamma in the glucose-sensing apparatus of liver and beta-cellsHa-Il Kim, Yong-Ho Ahn
JHEP Reports : Innovation in Hepatology|May 4, 2023
Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver diseaseJihye Lim, Hyunji Sang, Ha Il Kim
Digestive Diseases and Sciences|November 29, 2024
Association of Comorbidity Duration with the Occurrence and Prognosis of Steatotic Liver DiseaseHyunji Sang, Jihye Lim, Ha Il Kim
Journal of Cancer Research and Clinical Oncology|August 30, 2021
Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinomaHa Il Kim, Jihye Lim, Ju Hyun Shim
Intervirology|November 3, 2021
Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis BSara Jeong, Hyun Phil Shin, Ha Il Kim
Scientific Reports|March 24, 2021
Incidence and management patterns of alcohol-related liver disease in Korea: a nationwide standard cohort studyHa Il Kim, Seo Young Park, Hyun Phil Shin
Plos One|September 16, 2022
Impact of ultrasonographic blind spots for early-stage hepatocellular carcinoma during surveillanceJunghwan Lee, Su Bee Park, Soyoung Byun, et al.
Clinical and Molecular Hepatology|July 5, 2023
Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysisHa Il Kim, Jihyun An, Seungbong Han, et al.
Hepatology Communications|July 5, 2022
Ranking of transarterial and targeted therapies for advanced hepatocellular carcinoma in the era of immuno-oncology: A network meta-analysis of randomized sorafenib-controlled trialsJihyun An, Seungbong Han, Ha Il Kim, et al.
Plos One|August 27, 2020
Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinomaJihyun An, Ha Il Kim, Seheon Chang, et al.
Pageof 5